title: Renal transplantation at Allegheny General Hospital with special reference to the use of extreme-age cadaveric donors.
abstract: We report our experience with 25 living-donor and 427 cadaveric-donor kidneys followed for over 6 years. Patient survival exceeds 90% at 5 years for all recipients. Overall one-year and 5-year graft survival rates were 82.7% and 65.5%, respectively. Approximately one-third of CAD were of extreme age (eg, < or = 10 and > or = 60 years old). One-year and 5-year GS rates of this group were 72.2% and 54.8%, respectively. Kidneys from elderly donors probably should be given to age-matched recipients. Infant en bloc kidneys had good GS. They also adapted well their growth and function to adult recipients and should be used more frequently to alleviate the organ shortage problem. HLA mismatches, transplant PRA level, original kidney disease, and immunosuppressive regimens significantly affected the GS. Race, sex, cytomegaloviral antibody states, unacceptable antigens, length of pretransplant dialysis, and CAD cold ischemic time had no significant effect on GS.
authors.affiliation: Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
authors.forename: D D
authors.initials: DD
authors.lastname: Nghiem
authors.forename: S
authors.initials: S
authors.lastname: Hsia
authors.forename: B J
authors.initials: BJ
authors.lastname: Carpenter
authors.forename: S H
authors.initials: SH
authors.lastname: Chao
authors.forename: R J
authors.initials: RJ
authors.lastname: Marcus
authors.forename: M A
authors.initials: MA
authors.lastname: Palumbi
authors.forename: C L
authors.initials: CL
authors.lastname: Paul
authors.forename: B A
authors.initials: BA
authors.lastname: Kijanka
authors.forename: M A
authors.initials: MA
authors.lastname: Breckenridge
authors.forename: D F
authors.initials: DF
authors.lastname: Meleason
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002102:Cadaver; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D003710:Demography; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006648:Histocompatibility; D006801:Humans; D007223:Infant; D016030:Kidney Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009926:Organ Preservation; D010414:Pennsylvania; D012189:Retrospective Studies; D014019:Tissue Donors; D009927:Tissue and Organ Procurement
chemical_list: D016572:Cyclosporine